🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Please joins us and shine light on SCD SCDAI SCDAA 1st Annual Sickle Cell Disease Consortium October 8,2022 . Saturday. Inperson event. Venue: Crowne Plaza, West loop Chicago Speakers: Dr. Julie Kanter, Dr. Patrick Carroll Registration:free! urldefense.com/v3/__http:/www…

Our Fellow Dr. Dhilwayo received the Fellow’s award at Lynn Sage Breast Cancer Symposium. 😊👏🏼👏🏼👏🏼RUSH Cancer Center RUSH Internal Medicine Women's Leadership Council RUSH Heme/Onc

Please don’t forget to RSVP SCDAI RUSH Oak Park Hospital RUSH Cancer Center Rush University plexuscomm.com/cme-ce-activit…

Join us for the Sickle Cell Disease Clinical Consortium, a free educational program designed to help people with SCD manage their condition. Learn more and register for the Oct. 8 event in Chicago at rsh.md/sickle-cell.

urldefense.com/v3/__https:/ww…$. Thank you Mayor Lori Lightfoot for your support for 1st Annual Sickle Cell Disease Consortium. @chicagosmayor Rush University System for Health RUSH Cancer Center SCDAI

Great turnout for #SickleCell SCDAI Shivi Jain

Dr. Shivi Jain from Rush University Medical Center speaking at the first Sickle Cell Consortium meeting that she has organized at Chicago today along with her esteemed colleagues.

1st Annual Sickle Cell Disease Consortium, thank you to everyone who helped make it a success. Julie Kanter Rush University System for Health SCDAI @chicagosmayor RUSH Cancer Center RUSH Heme/Onc

👏🏽 Dr. Courtney Fitzhugh for pointing out there is no data that #hydroxyurea increases risk of malignancy compared to those not taking, and the benefits are so great, should not be withheld from patients w/ #sicklecell

Exactly this 👇🏽. #fixthesystem #sicklecelldisease #accesstocare

A much overdue great day for people with #sicklecelldisease. Now we need to implement these treatments. Safely. Efficiently. Ethically. Equally. National Alliance of Sickle Cell Centers will be here to help! fda.gov/news-events/pr…

Final results of Spartan single arm trial of crizanlizumab for secondary prevention of priapism in SCD. Reduced median episodes by 46% #ASH2023 #scd

🚨 Out now DREAMM-7 from NEJM BVd vs DVd NEJM Full disclosure: I am a co-author 🧵 BVd vs DVd in early relapse myeloma: N=494 (BVd, n=243; DVd, n=251) Median follow-up 28.2 months  Median Age: 65 High risk cytogenetics: 17% EMD: 5% vs 10% mLOT: 1 Prior dara 1% vs 2% PI

PERSEUS MRD Data: Maintenance upgraded MRD(-) responses up to 2-3 years later, and appears to be more profound with Dara-R maintenance. Dara-VRd/Dara-R doubled chances of reaching MRD negativity & sustaining it. I am more convinced of benefit of dara as part of maintenance #mmsm

Suggested approach to 1st relapse of myeloma post #ASCO24 Its suddenly more complicated-and bispecifics will change this too. Bela based triplets >> Dara/Bort/Dex, but CD38+Carfil/Dex still great. Safety of cilta-cel remains in Q, hard to broadly recommend for now. #mmsm

#ASH24 great talk by Rahul Banerjee, MD, FACP hopefully elimination of 24hr UPEP for follow up in MM will become a much needed practice change! No more urine in the fridge

Thank you Urvi Shah for this important research! Patients and Care Partners really appreciate this! #ASH24 #IMFASH24 #MMsm

Isa-KRd x 6 cycles Induction in NDMM: MIDAS Trial. N=791, VGPR 91%, MRD- 10-5 63%, MRD 10-6 47%, median CD34 collection: 7 x 10e6/kg Aurore Perrot ashpublications.org/blood/article-… #mmsm #bmtsm @BloodJournal

#Myeloma Paper of the Day: Phase 3 CEPHEUS study of Dara+VRd vs. VRd finds MRD-negativity 60.9% for quad vs. 39.4% w/ VRd; ≥CR rates 81.2% vs. 61.6%; sustained MRD negativity (≥12 mos) 48.7% vs. 26.3%, giving 43% lower progression or death risk: pubmed.ncbi.nlm.nih.gov/39910273/. #mmsm

Amyloid neuropathies are treatable and should not be missed. Gabriela F. Pucci, MD and I updated the Neudrawlogy amyloid neuropathy infographic and tweetorial that I share below. Remember that amyloid neuropathy is one of the causes of rapidly progressive neuropathy and that's why you